Literature DB >> 19745501

High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.

Jose Luis Arredondo-García1, Carlos F Amábile-Cuevas.   

Abstract

BACKGROUND: The prevalence of antimicrobial resistance among uropathogenic E. coli varies widely worldwide; to guide empirical therapy is necessary to have local, up-to-date susceptibility data.
METHODOLOGY: We tested 907 isolates from patients in Mexico City by disk diffusion and further characterized ciprofloxacin, cephalosporin and nitrofurantoin resistant strains.
RESULTS: Isolates were mostly resistant to ampicillin (74%), trimethoprim-sulfamethoxazole (60.1%) and ciprofloxacin (32.6%). The most effective drug was netilmicin (5.1% resistant) and the most effective of oral drugs was nitrofurantoin (7.4% resistant). Sixty-percent of ciprofloxacin-resistant strains had minimal inhibitory concentrations of 125 microg/ml or higher, well beyond urinary concentrations at the end of the 12-hour inter-dose period for standard oral regimes. Extended-spectrum beta-lactamases were detected in 6% of strains, most of them from community-acquired infections. All strains resistant to nitrofurantoin carried a 20 Kb plasmid, which when transformed into a susceptible recipient, conferred resistance to nitrofurantoin, ampicillin, sulfonamides, streptomycin, and partially protected against ciprofloxacin.
CONCLUSIONS: Drugs considered of choice against uncomplicated urinary tract infections are facing high resistance prevalences and resistance determinants formerly seen only at hospitals are now among community strains. Treatment guidelines from developed countries might not reflect these local trends.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19745501     DOI: 10.3855/jidc.195

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  7 in total

1.  Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Veronika J Wirtz
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

2.  Antibacterial activity of the essential oils from the leaves of Eucalyptus globulus against Escherichia coli and Staphylococcus aureus.

Authors:  Raho G Bachir; M Benali
Journal:  Asian Pac J Trop Biomed       Date:  2012-09

3.  Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan, Iran.

Authors:  Foroogh Neamati; Farzaneh Firoozeh; Mahmood Saffari; Mohammad Zibaei
Journal:  Jundishapur J Microbiol       Date:  2015-02-07       Impact factor: 0.747

4.  Prevalence, aetiology and antibiotic sensitivity profile of asymptomatic bacteriuria isolates from pregnant women in selected antenatal clinic from Nairobi, Kenya.

Authors:  Adelaide Ogutu Ayoyi; Gideon Kikuvi; Christine Bii; Samuel Kariuki
Journal:  Pan Afr Med J       Date:  2017-01-30

5.  Phenotypic & genotypic study of antimicrobial profile of bacteria isolates from environmental samples.

Authors:  Santhosh Kogaluru Shivakumaraswamy; Vijaya Kumar Deekshit; Rajeshwari Vittal; Dharnappa Sannejal Akhila; Dechamma Muthappa Mundanda; Juliet Roshini Mohan Raj; Anirban Chakraborty; Indrani Karunasagar
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

6.  Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.

Authors:  Daniela A López-Banda; Erika M Carrillo-Casas; Margarita Leyva-Leyva; Gabriel Orozco-Hoyuela; Ángel H Manjarrez-Hernández; Sara Arroyo-Escalante; David Moncada-Barrón; Silvia Villanueva-Recillas; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

7.  Efficacy of Locally Isolated Lactic Acid Bacteria Against Antibiotic-Resistant Uropathogens.

Authors:  Asma Manzoor; Ikram Ul-Haq; Shahjhan Baig; Javed Iqbal Qazi; Sanja Seratlic
Journal:  Jundishapur J Microbiol       Date:  2016-01-16       Impact factor: 0.747

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.